Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Tarceva erlotinib: Phase II data

Genentech Inc. (DNA), South San Francisco, Calif.
OSI Pharmaceuticals Inc. (OSIP), Melville, N.Y.
Product: Tarceva

Read the full 166 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE